The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
lar about cellular export mechanisms. <strong>The</strong> present study examined the hypothesis<br />
that the iron exporter ferroportin (FPN1) mediates cellular Mn export, using<br />
Xenopus laevis oocytes expressing human FPN1. When compared to oocytes expressing<br />
only the divalent metal transporter-1 (DMT1), 54 Mn accumulation was<br />
lower in oocytes also expressing FPN1. FPN1 expressing oocytes were able to significantly<br />
export 54 Mn when compared to control oocytes when injected with 16<br />
μM Mn (27% vs 7.5% respectively, over 4 h at pH 7.4). Export was concentrationdependent<br />
and could be partially cis-inhibited by 100 μM Fe, Co, and Ni, but not<br />
Rb. In addition, transport ability was lost at pH 5.5, but not at pH 8.5. Incubation<br />
in high K media was also able to partially inhibit Mn efflux in FPN1 expressing<br />
oocytes. <strong>The</strong>se results indicate that Mn is a substrate for FPN1, and the driving<br />
force is both pH and membrane potential-sensitive.<br />
313 CHARACTERIZATION OF ZIP8 AND ZIP14<br />
ZINC/BICARBONATE SYMPORTERS IN XENOPUS<br />
OOCYTES: CADMIUM AND ZINC UPTAKE AND<br />
INHIBITION BY VARIOUS METALS.<br />
M. Gálvez-Peralta, E. B. Hay, H. Li, M. Soleimani, E. Johansson, L. He, B.<br />
Wang and D. W. Nebert. University Cincinnati Medical Center, Cincinnati, OH.<br />
Cadmium (Cd) is a non-essential metal. Because <strong>of</strong> increases in cigarette smoking<br />
and the industrialization growth, Cd exposure in our environment is increasing<br />
dramatically. Chronic exposure to low doses <strong>of</strong> Cd can cause renal disease and osteomalacia.<br />
Cd is classified by IARC as a Category I human lung carcinogen. Cd<br />
uptake by mammalian cells uses Ca 2+ channels and SLC11A2 (DMT1). Previous<br />
studies from this lab have shown that bicarbonate-dependent Cd uptake is facilitated<br />
by SLC39A8 (ZIP8) and SLC39A14 (ZIP14) in mammalian cells. ZIP14<br />
and ZIP8 are divalent cation/HCO3 – symporters, whose endogenous function is<br />
primarily zinc uptake. ZIP14A and ZIP14B are distinctly different splice variants<br />
<strong>of</strong> exon 4. In addition to Cd––Hg, Pb, Pt and U are known to cause human renal<br />
Fanconi syndrome (renal proximal tubular acidosis). In this work, we inserted<br />
mouse ZIP8, ZIP14A and ZIP14B cDNA coding regions into the Xenopus vector<br />
pXFRM and performed transcription; capped RNA (cRNA) was microinjected<br />
into Xenopus oocytes. Km and Vmax values for Zn and Cd uptake were determined;<br />
competitive inhibition <strong>of</strong> Zn and Cd uptake by the three ZIP symporters<br />
was studied for Zn 2+ , Cd 2+ , Hg 2+ , Pb 2+ , Pt 2+ , U 2+ , Co 2+ , Cu 2+ , Ni 2+ , Cs 1+ , Mn 2+ and<br />
Fe 2+ . We found that Pt, U, Mn, Fe, Ni and Cs are significant inhibitors <strong>of</strong> Cd uptake<br />
by ZIP8; only high concentrations <strong>of</strong> Zn, Pt, Co, Mn and Cs inhibited Cd uptake<br />
by ZIP14A and ZIP14B. Differences in response were also observed for Zn<br />
uptake by the three ZIPs. Little is known about how ZIP14A and ZIP14B organspecific<br />
expression is regulated and why the two forms persist evolutionarily, but<br />
this study shows they differ in Cd and Zn uptake and competition against different<br />
metals. This study also suggests strongly that ZIP8 might play a major role in<br />
metal-induced renal Fanconi syndrome.-Supported by NIH grants R01 ES010416,<br />
P30 ES06096 (D.W.N.), T32 ES016646 (M.G.-P.), & R01 DK062809 (M.S.)<br />
314 ZIP8 AND ZIP14 ZINC/BICARBONATE SYMPORTERS:<br />
THEIR POSSIBLE ROLES DURING INFLAMMATION.<br />
Z. Wang 1 , M. Gálvez-Peralta 1 , C. M. Williams 1 , M. Liu 2 , D. L. Knoell 2 and D.<br />
W. Nebert 1 . 1 Environmental Health, University <strong>of</strong> Cincinnati Medical Center,<br />
Cincinnati, OH and 2 David Heart and Lung Research Institute, Ohio State<br />
University, Columbus, OH.<br />
SLC39A8 (ZIP8) and SLC39A14 (ZIP14) are divalent cation/HCO3 – symporters,<br />
primarily used for Zn uptake in vertebrate cells. Cd and other nonessential metals<br />
enter vertebrate cells by displacing Zn. SLC39A14 has two exons 4, giving celltype-specific<br />
expression <strong>of</strong> ZIP14A and ZIP14B as alternatively-spliced products,<br />
whereas SLC39A8 encodes a single product. Because Zn is involved in the host response<br />
to inflammatory stress, and inflammation induces hypozincemia, the objective<br />
<strong>of</strong> this project is to determine whether different inflammatory agents are able to<br />
induce changes in the expression <strong>of</strong> these transporters, and if this is organ-specific.<br />
C57BL/6J male mice were treated i.p. with TNF (5 μg/kg), IL6 (100 μg/kg) or<br />
LPS (5 mg/kg) and 12 tissues were collected at different times for qRT-PCR and<br />
Western blot. Because metallothionein and SLC11A2 (DMT1) have been associated<br />
with inflammation, their mRNA levels were also measured. To correlate<br />
changes in ZIP8, ZIP14A and ZIP14B with inflammation, we also measured TNF,<br />
IL6, and IL1B mRNA levels. We found significant differences in the response <strong>of</strong><br />
each organ, and ZIP mRNAs were induced at different times and patterns: heart<br />
showed the most highly TNF-induced ZIP8, ZIP14B mRNA levels; whereas ZIP8<br />
and ZIP14A mRNA reached their highest levels at 8 h, the peak <strong>of</strong> ZIP14B expression<br />
occurred when the levels <strong>of</strong> ZIP8 and ZIP14A were decreasing (16 h). <strong>The</strong>re<br />
was a double peak for interleukins in liver, heart and brain (1st peak at 2-4 h; 2nd<br />
peak at 16 h), suggesting an early vs late response; this pattern was also seen for<br />
ZIP14B mRNA. ZIP8 and ZIP14A mRNA levels were unchanged in liver or testis.<br />
Kidney ZIP8 and ZIP14A mRNA levels were significantly diminished. <strong>The</strong>se observations<br />
will help us understand how hypozincemia is regulated in various tissues,<br />
following an inflammatory response.-Supported, in part, by NIH grants R01<br />
ES010416 and P30 ES06096 (D.W.N.), T32 ES016646 (M.G.-P.) & R01<br />
HL08698 (D.L.K.)<br />
315 EVALUATION OF MUTAGENICITY, CHROMOSOME<br />
BREAKAGE, AND DNA DAMAGE BY PIG-A,<br />
MICRONUCLEUS AND COMET ASSAYS IN 28-DAY<br />
REPEATED DOSE TOXICITY STUDIES.<br />
J. Shi 1 , M. Paranjpe 1 , S. W. Bruce 1 , T. Kelley 1 , S. Springer 1 , J. Sly 1 , M. Klug 1 ,<br />
M. Arevaro 1 , S. Atta-Safoh 1 , F. Debelie 1 , L. Krsmanovic 1 , P. Sareen 1 and S.<br />
Dertinger 2 . 1 BioReliance Corporation, Rockville, MD and 2 Litron Laboratories,<br />
Rochester, NY.<br />
Integration <strong>of</strong> multiple in vivo genotoxicity endpoints into repeat dose general toxicity<br />
studies not only allows evaluating genotoxic potential <strong>of</strong> the test compounds<br />
with several endpoints which detect different genotoxic mode <strong>of</strong> action (MOA) in<br />
different organs, but also has the potential to reduce animal use. Here, we evaluated<br />
two genotoxic compounds, 7,12-dimethylbenz(a)anthracene (DMBA) and diethylnitrosamine<br />
(DEN) for Pig-a gene mutation and chromosomal damage in peripheral<br />
blood, and primary DNA damage in liver and blood cells in Sprague Dawley<br />
rats treated daily for 28 days. An additional treatment was performed 3 hours prior<br />
to necropsy on Study Day 29 for DNA damage evaluation. Peripheral blood samples<br />
obtained on Study Days -1, 15 and 29 were analyzed by flow cytometry to determine<br />
the frequencies <strong>of</strong> CD59-negative erythrocytes and reticulocytes (indicative<br />
<strong>of</strong> Pig-a gene mutation). Frequencies <strong>of</strong> micronucleated reticulocytes<br />
(%MN-RETs) were determined in peripheral blood obtained on Study Days 4 and<br />
29 by flow cytometry. As a result, DMBA induced dose-dependent increases <strong>of</strong><br />
CD59-negative erythrocytes/reticulocytes and MN-RETs, but no significant increase<br />
in DNA damage in liver cells when tested up to 10 mg/kg/day, which appears<br />
to be below the maximum tolerated dose. When tested up to 200 mg/kg/day in a<br />
follow up acute study, DMBA was determined positive in the liver Comet assay. On<br />
the other hand, DEN produced negative results in both the Pig-a mutation assay<br />
and the MN assay, and evaluation <strong>of</strong> Comet slides are still in progress. <strong>The</strong> different<br />
responses observed in the three genotoxicity endpoints induced by DMBA or DEN<br />
provided a characterization <strong>of</strong> the genotoxic MOA, target organs and a comparison<br />
<strong>of</strong> assay sensitivity under the experimental conditions.<br />
316 A NOVEL HIGH-THROUGHPUT IN VITRO MNT<br />
PROFILING ASSAY FOR SUSPENSION CELLS.<br />
S. Kirchner, M. Prummer, S. Marget-Müller, J. Muller, C. McGinnis, K.<br />
Kolaja, R. Werder, K. Christensen, S. Z<strong>of</strong>fmann, T. Enderle, R. Rietmann, D.<br />
Vögelin, P. Iaiza, C. Fattinger and T. Weiser. F. H<strong>of</strong>fmann-La Roche Ltd., CH-<br />
4070 Basel, Switzerland.<br />
<strong>The</strong> in vitro micronucleus assay is well established as an early tool to evaluate the<br />
aneugenic and/or clastogenic activity <strong>of</strong> potentially new drug candidates. <strong>The</strong> recent<br />
acceptance <strong>of</strong> OECD TG487 by regulatory agencies positions the in vitro<br />
MNT as an alternative for both the GLP in vitro chromosomal aberration assay and<br />
the L5178Y Mouse Lymphoma assay. This allows for the first time to use the same<br />
assay and cell system throughout the different stages <strong>of</strong> testing in the drug development<br />
process with its specific needs. So far standard suspension cell lines used for in<br />
vitro micronucleus evaluation such as L5178Y and TK6 were only accessible to true<br />
high throughput applications by means <strong>of</strong> flow cytometry not allowing for analysis<br />
on a single cell level. We are presenting here a novel and universal approach to prepare<br />
arrays <strong>of</strong> non-adherent cells from 96-well plates for automated microscopy and<br />
micronucleus evaluation to fill this gap. For image segmentation and object classification<br />
we co-developed an adaptive and iterative algorithm for L5178Y cells using<br />
Definiens Cognition Network Technology and non-parametric statistical methods<br />
were applied to classify the micronucleation potential. To validate the assay protocol<br />
we compared the results obtained between the high throughput 96-well plate<br />
method and a regulatory like in vitro micronucleus screening assay for selected reference<br />
and 224 in house compounds using L5178Y cells. Based on these experiences,<br />
this high throughput in vitro MNT approach will be compared and contrasted<br />
within the context <strong>of</strong> supporting the early development <strong>of</strong> drug candidates.<br />
In summary, these developments open up new possibilities for aligning the clastogenicity/aneugenicity<br />
assessment throughout the drug development process from<br />
HT approaches to regulatory like screening and regulatory testing when using suspension<br />
cells. In addition this development might also have the potential to make<br />
human primary lymphocytes more accessible to higher throughput applications.<br />
SOT 2011 ANNUAL MEETING 67